| AME |
Report |
Organic Growth (%) |
BEAT |
pred ~+6.5% vs. cons +5.0% |
MEDIUM |
| AME |
Report |
Operating Margin - Operating (%) |
BEAT |
pred ~27.2% vs. cons 26.81% |
MEDIUM |
| AME |
Report |
Orders ($B) |
BEAT |
pred ~$2.07B vs. cons $1.99B |
MEDIUM |
| AME |
Guide |
Adj. EPS FY 2026 (FY 2026) |
BETTER |
guide ~$8.30 midpoint vs. cons ~$7.99 adj. |
MEDIUM |
| AME |
Guide |
Q3 2026 EPS (Q3 2026) |
BETTER |
guide ~$2.07 vs. cons ~$2.00 |
MEDIUM |
| AME |
Guide |
Organic Growth FY 2026 (FY 2026) |
BETTER |
guide ~mid-to-upper single digits (~6%) vs. cons ~5.2% |
MEDIUM |
| AME |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.5% |
— |
MEDIUM |
| AME |
Return |
5-day cumulative residual |
+3.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — estimate revisions track the raised FY guide into H2 out-period math |
MEDIUM |